SCHEMBL3772038

SCHEMBL3772038

Cc1noc(NC(=O)N2CCN(c3nc(-c4ccccc4)cs3)CC2)c1Cl

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 6/20 0.68
RAB9A P51151 3/20 0.55
NPC1 O15118 2/20 0.55
ALDH1A1 P00352 5/20 0.54
HSD17B10 Q99714 2/20 0.54
MAPT P10636 9/20 0.54
MAPK1 P28482 6/20 0.54
LMNA P02545 5/20 0.54
NPSR1 Q6W5P4 3/20 0.53
HTT P42858 3/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
GAA P10253 2/20 0.52
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
TP53 P04637 1/20 0.50
TSHR P16473 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3769724 0.90 FAAH (0.73) FAAHRAB9ANPC1ALDH1A1HSD17B10
SCHEMBL3766248 0.84 FAAH (0.61) FAAHRAB9AALDH1A1HSD17B10MAPT
SCHEMBL3765815 0.83 FAAH (0.68) FAAHRAB9ANPC1MAPTMAPK1
SCHEMBL3767177 0.82 FAAH (0.71) FAAHRAB9ANPC1ALDH1A1HSD17B10
SCHEMBL3772075 0.81 FAAH (0.62) FAAHRAB9ANPC1ALDH1A1HSD17B10
SCHEMBL3771739 0.81 FAAH (0.60) FAAHRAB9ANPC1ALDH1A1HSD17B10
SCHEMBL3761321 0.81 FAAH (0.74) FAAHRAB9ANPC1ALDH1A1MAPT
SCHEMBL3771872 0.80 FAAH (0.56) FAAHRAB9ANPC1ALDH1A1HSD17B10
SCHEMBL3772454 0.80 FAAH (0.75) FAAHRAB9ANPC1ALDH1A1HSD17B10
SCHEMBL3763272 0.79 MAPT (0.72) FAAHALDH1A1HSD17B10MAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851473-B2 Amide compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-12-14 US disclosed
US-20080312226-A1 Amide Compound TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2008-12-18 US disclosed
EP-1813606-A1 AMIDE COMPOUND Takeda Pharmaceutical Company Limited (JP) 2007-08-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080312226-A1 Amide Compound FAAH, FAAH2, CNR2 FAAH 1/4885RAB9A 1416/4885NPC1 1078/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.